We use cookies to ensure that we give you the best experience on our website. It will mean you have agreed with we would get cookies when you continue to see this website.

About Us

Company Information

Group Name Remedy & Company Corporation
Founder and CEO Masakuni Ukita
Date of Establishment August 2005
Main Scope of Service 1. DX solutions and consulting business for medical and pharmaceutical development.
2. Business to establish a platform for advanced medical care in Japan and overseas.
Address 1-1-10 Ueno, Taito-ku, Tokyo, Japan
TEL:
03-6695-0400
FAX:
03-6695-0401

We request that you to notify us your caller ID in order to offer better quality service.
Customers who are choosing anonymous call setting, please use caller ID function.
Thank you for your cooperation.

Special Adviser Prof. Hideyuki Okano
Prof. Suzuki Yasuhiro
Group Companies intellim Corporation
intellim Taiwan
intellim Korea
intellim Malaysia
intellim China
intellim Thailand
intellim Europe
intellim Vietnam
iRIS Corporation
Quantum Healthcare Corporation
For inquiries regarding integrated pharmaceutical development,please contact us here.

History

2005
August intellim Corporation is founded (Head Office Osaka; Branch Office Tokyo)
2008
January Tokyo Clinical Development Center is established and CRO Business launches
April Osaka Clinical Development Center is opened
2011
November Dr. Nagahiro Saijo is invited as Medical Adviser
2012
May Taiwan Office established
September intellim Korea established
November intellim partners with QPS Holdings and establishes iQ Pharma Services
2015
October Dr. Akio Urabe is invited as Medical Adviser
2017
September intellim moves Head Office to Tokyo
2018
March Malaysian Governmental NPO Organization, CRM(Clinical Research Malaysia) and intellim execute a basic agreement on Drug Development Support
April iRIS Corporation is founded
intellim Holdings Corporation (now Remedy & Company Corporation) is founded
June intellim Malaysia is founded
2019
May intellim China is founded
June Quantum Healthcare Corporation is founded
October intellim Thailand is founded
November intellim Europe is founded
2020
June intellim Vietnam is founded
2021
February Prof. Hideyuki Okano is invited as Medical Adviser
March Prof. Suzuki Yasuhiro is invited as Medical Adviser
2022
April intellim Holdings Corporation changes its name to Remedy & Company Corporation.
For inquiries regarding integrated pharmaceutical development,please contact us here.

Adviser

岡野 栄之教授

Prof.
Hideyuki Okano

Professor at Keio University School of Medicine Department of Physiology

【Key research area 】
Molecular neurobiology, developmental biology, regenerative medicine

Prof. SUZUKI Yasuhiro

Prof.
Suzuki Yasuhiro

Adviser and Former Vice-Minister and Chief Medical & Global Health Officer, Ministry of Health, Labour and Welfare

International Locations

Please click here for information on the Remedy Group, including information on our overseas offices.
Europe
intellim Europe
East Asia
intellim China
intellim Korea
intellim Taiwan
Southeast Asia
intellim Thailand
intellim Malaysia
intellim Vietnam